Journal News

A mold’s dangerous responses to its environment

Laurel Oldach
Jan. 19, 2021

Aflatoxins are among the most dangerous of natural products. At a high dose, the toxins can cause fatal liver failure; at lower doses, by forming adducts with guanine bases in DNA, they can cause mutations that lead to liver cancer.

Mold-445x334.jpg
Janice Haney Carr and Robert Simmons
A scanning electron micrograph shows the fruiting body of an Aspergillus fungus.

The toxins are made by filamentous fungi in the Aspergillus family found in soil and are able to colonize the grains and seeds that constitute many of the world's most important food crops. Aspergilli don't need aflatoxins to survive; they activate aflatoxin synthesis in response to environmental conditions, especially heat and moisture. Since hotter days are coming worldwide, researchers would like to find strategies to reduce aflatoxin production.

The genome of Aspergillus flavus, the chief culprit in introducing aflatoxin to human and animal food supplies, first was sequenced in 2006. But there's a difference between knowing what sequences are in a genome and knowing what they do; many sections of the A. flavus genome have not been annotated, meaning that researchers have had little insight into their function.

In a recent article in the journal Molecular & Cellular Proteomics, researchers at the Fujian Agriculture and Forestry University in China, led by Mingkun Yang, report on a proteogenomic analysis of A. flavus. By using the whole fungal genome instead of only its known coding sequences as the reference database to identify peptides detected through mass spectrometry, the team discovered over 700 new protein-coding genes.

"The authors provide a significant improvement to the genome annotation in Aspergillus and demonstrate the use of proteogenomics as a tool especially in organisms lacking high-quality genome annotations," one anonymous peer reviewer wrote.

Researchers cultured the fungus under cold, salty and oxidative stress conditions to maximize phenotypic variability, and they were rewarded: The fungi expressed a smorgasbord of proteoforms, including over 200 new-to-science splice variants, some single-amino-acid variants and a few unexpected intergenic peptides. In follow-up quantitative PCR experiments, the researchers observed that stressful conditions substantially affected the expression of some of the new genes.

Based on homology to other, better-annotated proteins in the literature, the authors think that they may have identified new metabolic enzymes, signaling proteins and stress response factors. They have not yet determined whether any of the new genes are involved in aflatoxin production.

According to the researchers, follow-up studies of the new protein-coding genes and when and where they are expressed may improve our understanding of when and why aflatoxin is produced.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Laurel Oldach

Laurel Oldach is a former science writer for the ASBMB.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Avoiding common figure errors in manuscript submissions
How-to

Avoiding common figure errors in manuscript submissions

Feb. 27, 2026

The three figure issues most often flagged during JBC’s data integrity review are background signal errors, image reuse and undeclared splicing errors. Learn how to avoid these and prevent mistakes that could impede publication.

Ragweed compound thwarts aggressive bladder and breast cancers
Journal News

Ragweed compound thwarts aggressive bladder and breast cancers

Feb. 26, 2026

Scientists from the University of Michigan reveal the mechanism of action of ambrosin, a compound from ragweed, selectively attacks advanced bladder and breast cancer cells in cell-based models, highlighting its potential to treat advanced tumors.

Lipid-lowering therapies could help treat IBD
Journal News

Lipid-lowering therapies could help treat IBD

Feb. 25, 2026

Genetic evidence shows that drugs that reduce cholesterol or triglyceride levels can either raise or lower inflammatory bowel disease risk by altering gut microbes and immune signaling.

Key regulator of cholesterol protects against Alzheimer’s disease
Journal News

Key regulator of cholesterol protects against Alzheimer’s disease

Feb. 24, 2026

A new study identifies oxysterol-binding protein-related protein 6 as a central controller of brain cholesterol balance, with protective effects against Alzheimer’s-related neurodegeneration.

From humble beginnings to unlocking lysosomal secrets
Award

From humble beginnings to unlocking lysosomal secrets

Feb. 20, 2026

Monther Abu–Remaileh will receive the ASBMB’s 2026 Walter A. Shaw Young Investigator Award in Lipid Research at the ASBMB Annual Meeting, March 7-10 in Washington, D.C.

Chemistry meets biology to thwart parasites
Award

Chemistry meets biology to thwart parasites

Feb. 19, 2026

Margaret Phillips will receive the Alice and C. C. Wang Award in Molecular Parasitology at the ASBMB Annual Meeting, March 7-10 in Washington, D.C.